ETF Managers Group’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | $713K | Buy |
+94,496
| New | +$713K | 0.02% | 326 |
|
|
2022
Q4 | – | Sell |
-84,143
| Closed | -$832K | – | 515 |
|
|
2022
Q3 | $832K | Sell |
84,143
-5,752
| -6% | -$56.9K | 0.03% | 233 |
|
|
2022
Q2 | $909K | Buy |
89,895
+3,772
| +4% | +$38.1K | 0.03% | 245 |
|
|
2022
Q1 | $840K | Buy |
86,123
+1,018
| +1% | +$9.93K | 0.02% | 328 |
|
|
2021
Q4 | $1.22M | Sell |
85,105
-16,659
| -16% | -$239K | 0.02% | 252 |
|
|
2021
Q3 | $1.98M | Buy |
101,764
+21,792
| +27% | +$424K | 0.04% | 202 |
|
|
2021
Q2 | $1.7M | Buy |
79,972
+7,348
| +10% | +$156K | 0.03% | 238 |
|
|
2021
Q1 | $1.94M | Buy |
+72,624
| New | +$1.94M | 0.03% | 193 |
|